JANX — Janux Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapFalling Star

Annual balance sheet for Janux Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	375	327	344	1,025	967
Net Total Accounts Receivable
Net Total Receivables	0	—	—	—	6.43
Prepaid Expenses
Total Current Assets	377	332	349	1,034	976
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.6	29.4	27.8	24.1	22.3
Other Long Term Assets
Total Assets	380	364	380	1,062	1,002
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	12.8	16.5	13	17.5	25
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	13.5	43.3	36.1	38.7	44.7
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	366	321	344	1,023	957
Total Liabilities & Shareholders' Equity	380	364	380	1,062	1,002
Total Common Shares Outstanding